Biographical summary
Dr. Anand Srinivasan is a board-certified pediatric hematologist-oncologist with a specialization in hematopoietic stem cell transplantation and cellular therapy. He provides advanced care for children, teens and young adults with blood disorders and cancer.
His clinical interest includes:
- Allogeneic hematopoietic stem cell transplantation
- Cellular therapy
- Haploidentical transplantation using post-transplant cyclophosphamide
- Graft-versus-host disease
In addition to his clinical interests, Dr. Srinivasan has a strong interest in medical education and provides mentorship to medical students, residents, and fellows.
Conditions treated
- Acute leukemia
- Aplastic anemia
- Bone marrow failure syndromes
- Immune deficiencies
Procedures performed
Interests
- Pediatric hematopoietic stem cell transplantation
- Haploidentical stem cell transplantation
- Cellular therapy
- Bone marrow failure syndromes
Mayo Clinic locations
Education
- 2021
Fellow - Pediatric Transplant/Cellular TherapyUniversity of Toronto, The Hospitals for Sick Children
- 2020
Fellow - Pediatric Hematology OncologyUniversity of Oklahoma Health Sciences Center
- 2017
Resident - PediatricsColumbia University/The Affiliation at Harlem Hospital
- 2013
BS and MSAmrita School of Medicine
Activities and honors
Awards and honors
- 2023
Translating Practice into Research (TPIR) Trainee ProgramOklahoma Shared Clinical and Translational Resources
- 2022
Medical Educators Institute awardAmerican Society of Hematology
- 2020
Student research travel awardStephenson Cancer Center
- 2019
ASTCT Travel grant awardAmerican Society of Transplantation and Cellular Therapy
- 2019
Oral presentation award, Pediatric research day “Mouse models of graft versus host disease: Path to testing new therapeutics”University of Oklahoma Health Sciences Center
Professional memberships
- 2022 - 2024
Commiittee MemberPediatric Hematology/Oncology Committee, University of Oklahoma Children’s Hospital
- 2022 - 2024
Commiittee MemberOU Health Pharmacy & Therapeutics Committee, University of Oklahoma Children’s Hospital
- 2022 - present
MemberPediatric Transplant and Cell Therapy
- 2022 - present
Immune Reconstitution Study Committee MemberChildren's Oncology Group
- 2021 - present
Reviewer/Board MemberInstitutional Review Board, Oklahoma Medical Research Foundation; Institutional Review Board
- 2018 - 2020
Fellow RepresentativePediatric Bone Marrow Transplant Consortium, Children's Oncology Group
- 2018 - present
MemberAmerican Society of Clinical Oncology
- 2017 - present
MemberChildren's Oncology Group
- 2017 - present
MemberAmerican Society for Transplantation and Cellular Therapy
Publications